3. U.S. Food & Drug Administration. Drug Approval Package: Cuprimine. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf
5. Ishak R, Abbas O. Penicillamine revisited: historic overview and review of the clinical uses and cutaneous adverse effects. Am J Clin Dermatol. 2013 Jun;14(3):223-33. https://doi.org/10.1007/s40257-013-0022-z
7. Aaseth J, Skaug MA, Cao Y, Andersen O. Chelation in metal intoxication--Principles and paradigms. J Trace Elem Med Biol. 2015;31:260-6. https://doi.org/10.1016/j.jtemb.2014.10.001
16. Pitman SK, Huynh T, Bjarnason TA, et al. A case report and focused literature review of d-penicillamine and severe neutropenia: A serious toxicity from a seldom-used drug. Clin Case Rep. 2019 Apr 9;7(5):990-994. https://doi.org/10.1002/ccr3.2125